Dyne Therapeutics, Inc. (DYN)
17.92
-0.14
(-0.78%)
USD |
NASDAQ |
Mar 13, 16:00
17.91
-0.01
(-0.06%)
After-Hours: 20:00
Dyne Therapeutics Shareholders Equity (Quarterly) : 972.13M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Amicus Therapeutics, Inc. | 274.24M |
| Insmed, Inc. | 738.98M |
| MannKind Corp. | -51.02M |
| Sarepta Therapeutics, Inc. | 1.141B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.187B |
| Total Liabilities (Quarterly) | 214.83M |
| Debt to Equity Ratio | 0.1741 |
| Current Ratio | 22.25 |
| Net Debt Paydown Yield | -0.89% |